467
edits
Cardiac Pharmacology: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 368: | Line 368: | ||
|Heart Failure | |Heart Failure | ||
|Captopril: 12.5mg 3 times daily | |Captopril: 12.5mg 3 times daily | ||
|ESC Guidelines (European Heart Journal (2012) 33, 2569–2619 | |ESC Guidelines (European Heart Journal (2012) 33, 2569–2619 doi:10.1093/eurheartj/ehs215): | ||
doi:10.1093/eurheartj/ehs215): | |||
Post STEMI: Class IA | Post STEMI: Class IA | ||
ESC and EASD Guidelines (European Heart Journal doi: 10.1093/eurheart/ehl261) | ESC and EASD Guidelines (European Heart Journal doi: 10.1093/eurheart/ehl261) | ||
Diabetic patients: Class IC | Diabetic patients: Class IC | ||
| Line 400: | Line 399: | ||
| | | | ||
|Angiotensin Receptor Blockers | |Angiotensin Receptor Blockers | ||
|Losartan. Candesartan |Hypertension | |Losartan. Candesartan | ||
|Hypertension | |||
|Losartan: 50mg once daily | |Losartan: 50mg once daily | ||
|ESC and EASD Guidelines (European Heart Journal doi: 10.1093/eurheart/ehl261) | |ESC and EASD Guidelines (European Heart Journal doi: 10.1093/eurheart/ehl261) | ||
| Line 507: | Line 507: | ||
AF (Stable flutter): Class IC | AF (Stable flutter): Class IC | ||
Prophylaxis of SVT during pregnancy: Class IIaB | Prophylaxis of SVT during pregnancy: Class IIaB | ||
| | |||
|- | |- | ||
| | | | ||
| Line 542: | Line 543: | ||
doi:10.1093/eurheartj/ehs104): | doi:10.1093/eurheartj/ehs104): | ||
Angina in symptomatic (NYHA class II-IV) HF and LVD: Class IIaA | Angina in symptomatic (NYHA class II-IV) HF and LVD: Class IIaA | ||
| | |||
|- | |- | ||
|Anti-Arrhythmics | |Anti-Arrhythmics | ||